Cargando…
HNF1A regulates oxaliplatin resistance in pancreatic cancer by targeting 53BP1
DNA double-strand break repair is critically involved in oxaliplatin resistance in pancreatic ductal adenocarcinoma (PDAC). Hepatocyte nuclear factor 1 homeobox A (HNF1A) has received increased attention regarding its role in cancer progression. The present study explored the role of HNF1A in oxalip...
Autores principales: | Xia, Renpeng, Hu, Chonghui, Ye, Yuancheng, Zhang, Xiang, Li, Tingting, He, Rihua, Zheng, Shangyou, Wen, Xiaofeng, Chen, Rufu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990585/ https://www.ncbi.nlm.nih.gov/pubmed/36825600 http://dx.doi.org/10.3892/ijo.2023.5493 |
Ejemplares similares
-
circFARP1 enables cancer-associated fibroblasts to promote gemcitabine resistance in pancreatic cancer via the LIF/STAT3 axis
por: Hu, Chonghui, et al.
Publicado: (2022) -
Cancer-associated fibroblast-induced lncRNA UPK1A-AS1 confers platinum resistance in pancreatic cancer via efficient double-strand break repair
por: Zhang, Xiang, et al.
Publicado: (2022) -
Extracellular vesicle-packaged circBIRC6 from cancer-associated fibroblasts induce platinum resistance via SUMOylation modulation in pancreatic cancer
por: Zheng, Shangyou, et al.
Publicado: (2023) -
circCUL2 induces an inflammatory CAF phenotype in pancreatic ductal adenocarcinoma via the activation of the MyD88-dependent NF-κB signaling pathway
por: Zheng, Shangyou, et al.
Publicado: (2022) -
A novel gene signature for prognosis prediction and chemotherapy response in patients with pancreatic cancer
por: Lin, Hongcao, et al.
Publicado: (2021)